𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases

✍ Scribed by Yasuhiro Shirai; Sumio Kawata; Shinji Tamura; Nobuyuki Ito; Hirofumi Tsushima; Kenji Takaishi; Shinichi Kiso; Yuji Matsuzawa

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
455 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor-β1 : A useful
Transforming growth factor-β1 : A useful tumor marker in patients with colorectal carcinoma?
✍ Alan D. Langerak; Harinder S. Garewal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

T he report by Shim et al. 1 in this issue of Cancer presents interesting data regarding the potential use of serum transforming growth factor (TGF)-␤1 levels as a tumor marker in patients with colorectal carcinoma. Their findings suggest that TGF-␤ may be helpful in predicting extent of disease and

Plasma transforming growth factor-β1 lev
Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma
✍ Fengming Kong; Randy L. Jirtle; Dale H. Huang; Robert W. Clough; Mitchell S. Ans 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views

## BACKGROUND. Plasma transforming growth factor-␤1 (TGF␤1) levels are increased in many malignancies at the time of diagnosis, including all forms of lung carcinoma. Therefore, the potential use of TGF␤1 as a plasma marker to predict the long term outcome of lung carcinoma patients treated with r